Michael Pinchas Rubin
Amministratore Delegato presso Northpond Ventures LLC
Profilo
Michael Pinchas Rubin is the founder of Sands Capital Ventures LLC (founded in 2010) and Northpond Ventures LLC (founded in 2018).
At Sands Capital Ventures LLC, he held the title of Chief Executive Officer from 2013 to 2018.
At Northpond Ventures LLC, he currently holds the title of CEO.
Dr. Rubin's current jobs include serving as a Non-Executive Director at SpeeDx Pty Ltd.
and as a Director at Scipher Medicine Corp.
Dr. Rubin's former jobs include serving as a Director at Complete Genomics, Inc., DiCE Therapeutics, Inc., and DICE Molecules SV, Inc., and as a Medical Analyst at Sands Capital Management LLC from 2008 to 2010.
He also served as a Physician & Scientist at Massachusetts Eye & Ear Infirmary, Inc. in 2007.
Dr. Rubin received his undergraduate degree from the University of California, Los Angeles in 1998, his doctorate from Pritzker School of Medicine in 2002, and his MBA from The Isenberg School of Management in 2010.
Posizioni attive di Michael Pinchas Rubin
Società | Posizione | Inizio |
---|---|---|
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | Amministratore Delegato | 01/05/2018 |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Direttore/Membro del Consiglio | - |
Scipher Medicine Corp.
Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Pinchas Rubin
Società | Posizione | Fine |
---|---|---|
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | Amministratore Delegato | 01/04/2018 |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA. | Corporate Officer/Principal | 31/12/2007 |
DICE THER | Direttore/Membro del Consiglio | - |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | - |
COMPLETE GENOMICS, INC. | Direttore/Membro del Consiglio | 12/11/2010 |
Formazione di Michael Pinchas Rubin
University of California, Los Angeles | Undergraduate Degree |
The Isenberg School of Management | Masters Business Admin |
Pritzker School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 9 |
---|---|
Sands Capital Management LLC
Sands Capital Management LLC Investment ManagersFinance Sands Capital Management LLC (Sands Capital) is a SEC-registered investment advisor headquartered in Arlington, Virginia. The firm was founded in 1992 by Frank Sands and is majority owned by Sands Capital Management LP. Sands Capital provides investment management services to both US and non-US clients who have different tax statuses, often depending on the jurisdiction. | Finance |
Complete Genomics, Inc.
Complete Genomics, Inc. BiotechnologyHealth Technology Complete Genomics, Inc. develops and markets DNA sequencing technology. It provides complete genomics analysis platform, which combines its proprietary human genome sequencing technology with the company's advanced informatics and data management software. The firm offers innovative, end-to-end, outsourced service model to the customers with data. The company was founded by Clifford A. Reid, Radoje T. Drmanac, David Smith and Robert John Curson in 2006 and is headquartered in San Jose, CA. | Health Technology |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA. | Health Services |
SpeeDx Pty Ltd.
SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Health Technology |
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | Finance |
DICE Therapeutics, Inc.
DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
Scipher Medicine Corp.
Scipher Medicine Corp. Medical SpecialtiesHealth Technology Scipher Medicine Corp. operates as a biotechnology firm, which uses human data to predict drug response. It visualize overlaps between disease, drug and patient data. The company was founded in 2013 and is headquartered in Boston, MA. | Health Technology |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland. | Finance |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Finance |
- Borsa valori
- Insiders
- Michael Pinchas Rubin